• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

1,002.31 -4.76 (-0.47%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 209,935
Open 991.68
Bid (Size) 957.40 (200)
Ask (Size) 1,181.00 (40)
Prev. Close 1,007.07
Today's Range 988.69 - 1,008.93
52wk Range 661.85 - 1,072.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today ↗
September 04, 2026
argenx (NASDAQ:ARGX) has outperformed the market over the past 5 years by 13.58% on an annualized basis producing an average annual return of 24.86%. Currently, argenx has a market capitalization of... 
Via Benzinga
News headline image
Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated? ↗
September 02, 2026
This biotech innovator could be in only the early chapters of its success story. 
Via The Motley Fool

Performance

YTD
+19.3%
+19.3%
1 Month
+15.7%
+15.7%
3 Month
+16.3%
+16.3%
6 Month
+37.7%
+37.7%
1 Year
+30.7%
+30.7%

More News

Read More
News headline image
argenx to Present at Upcoming Investor Conferences
September 01, 2026
From argenx SE
Via GlobeNewswire
News headline image
argenx Completes Acquisition of Forte Biosciences, Inc.
August 27, 2026
From argenx SE
Via GlobeNewswire
News headline image
Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story ↗
August 26, 2026
Via The Motley Fool
News headline image
Snowflake To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
August 18, 2026
Via Benzinga
News headline image
These Analysts Boost Their Forecasts On Argenx ↗
August 18, 2026
Via Benzinga
There are notable gap-ups and gap-downs in today's session. ↗
August 17, 2026
Via Chartmill
News headline image
argenx VYVGART Hits Phase III Goal in Autoimmune Myositis, Eyes IMNM Filing ↗
August 17, 2026
Via MarketBeat
Topics Intellectual Property
News headline image
$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today ↗
August 17, 2026
Via Benzinga
News headline image
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
August 17, 2026
From argenx SE
Via GlobeNewswire
News headline image
Here’s How Much You Would Have Made Owning argenx Stock In The Last 5 Years ↗
August 10, 2026
Via Benzinga
News headline image
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
August 06, 2026
From argenx SE
Via GlobeNewswire
News headline image
argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026
August 03, 2026
From argenx SE
Via GlobeNewswire
News headline image
argenx Strikes $2.2B Deal for Forte, Adds Autoimmune Drug FB102 ↗
July 27, 2026
Via MarketBeat
Topics Intellectual Property
News headline image
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline
July 27, 2026
From Forte Biosciences, Inc.
Via Business Wire
News headline image
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
July 27, 2026
From argenx SE
Via GlobeNewswire
News headline image
argenex Q2 Earnings Call Highlights ↗
July 23, 2026
Via MarketBeat
Topics Earnings Intellectual Property
News headline image
argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update
July 23, 2026
From argenx SE
Via GlobeNewswire
News headline image
argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026
July 16, 2026
From argenx SE
Via GlobeNewswire
News headline image
argenx to Host Autoimmune Myositis R&D Webinar
June 23, 2026
From argenx SE
Via GlobeNewswire
News headline image
argenx Eyes More VYVGART Growth as Pipeline Catalysts Near ↗
June 12, 2026
Via MarketBeat
Topics Intellectual Property Supply Chain
News headline image
argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference ↗
June 05, 2026
Via MarketBeat
Topics Intellectual Property
News headline image
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026
June 03, 2026
From argenx SE
Via GlobeNewswire
News headline image
Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800% ↗
May 29, 2026
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is argenx SE - American Depositary Shares publicly traded?
Yes, argenx SE - American Depositary Shares is publicly traded.
What exchange does argenx SE - American Depositary Shares trade on?
argenx SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for argenx SE - American Depositary Shares?
The ticker symbol for argenx SE - American Depositary Shares is ARGX on the Nasdaq Stock Market
What is the current price of argenx SE - American Depositary Shares?
The current price of argenx SE - American Depositary Shares is 1,002.31
When was argenx SE - American Depositary Shares last traded?
The last trade of argenx SE - American Depositary Shares was at 09/09/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap